A company using artificial intelligence in the drug discovery and validation process and a company developing long-lasting “irreversible” drugs for the treatment of certain cancers are a pair of recent biotech IPOs that “have unique value for investors that could make them worth a (speculative) buy,” advises the author of today’s article. For more on these two hot biotech IPOs, CLICK HERE.
2 Recent Biotech IPOs That Could Be Worth A Speculative Buy
- by RobH
![](https://www.hotstockanalyst.com/wp-content/uploads/2021/04/2021-04-29-21_37_30-purple-cells-photo-–-Free-Image-on-Unsplash.png)
Tags:Artificial IntelligenceBiotech InvestmentsBiotech IPOBiotech IPOsBiotech SectorInvestingInvestorSpeculative BuysStock MarketUnique Value